Activated Gαq family members induce Rho GTPase activation and Rho-dependent actin filament assembly  by Dutt, Parmesh et al.
Activated GKq family members induce Rho GTPase activation and
Rho-dependent actin ¢lament assembly
Parmesh Dutta, Lars Kjollerb;1, Maryann Giela, Alan Hallb, Deniz Toksoza;
aPhysiology Department, 136 Harrison Avenue, Tufts University School of Medicine, Boston, MA 02111, USA
bMRC Laboratory for Molecular Cell Biology, Cancer Research UK Oncogene and Signal Transduction Group, University College London,
Gower Street, London WC1E 6BT, UK
Received 14 October 2002; accepted 17 October 2002
First published online 1 November 2002
Edited by Jesus Avila
Abstract Rho GTPase is required for actin ¢lament assembly
and serum response element (SRE)-dependent gene transcrip-
tion. Certain G protein-coupled receptors (GPCRs) induce
Rho-dependent responses, but the intermediary signaling steps
are poorly understood. The heterotrimeric GK12 family can
induce Rho-dependent responses. In contrast, there are con£ict-
ing reports on the role of the GKq family in Rho signaling. We
report that expression of activated GKq members, or activation
of endogenous GKq via GPCR stimulation, induces SRE report-
er activation via Rho, and increased GTP-Rho levels. Moreover,
microinjection of activated GKq in ¢broblasts induces actin
stress ¢ber formation via Rho. GKq functionally cooperates
with Lbc Rho guanine nucleotide exchange factor. Overall,
these ¢ndings indicate that GKq family signals are su⁄cient
to induce Rho-dependent cellular responses.
0 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The ubiquitous Rho small GTPase is required for multiple
cellular responses such as cell growth, contraction, retraction
and migration [1]. Rho controls a distinct signaling pathway
that regulates actin ¢lament assembly [2] and serum response
factor (SRF)-dependent gene transcription [3]. Moreover, de-
fective Rho signaling is implicated in diseases such as cancer
and cardiovascular defects [4^6]. However, early regulatory
steps in the Rho pathway are poorly understood.
Rho signaling is rapidly induced by serum, and many of the
stimulatory serum components are G protein-coupled recep-
tor (GPCR) agonists such as lysophosphatidic acid, thrombin,
and agonists for the K1-adrenergic and M1 muscarinic
GPCRs which induce actin polymerization and serum re-
sponse element (SRE) transcriptional reporter activation via
Rho [7]. Moreover, it is now clear that the mechanisms of
GPCR-induced Rho responses involve GK subunits of hetero-
trimeric GTPases [7]. For example, actin ¢lament assembly,
a Rho-dependent cytoskeletal response [8], is induced by mi-
croinjection of activated forms of the GK12 family, GK12QL
or GK13QL, into ¢broblasts [9]. Based on these and other
studies, it is now well established that GK12 and GK13 signals
induce Rho activation and subsequent cellular responses.
Moreover, the mechanism by which GK13 activates Rho has
been de¢ned in vitro, and requires a Rho guanine nucleotide
exchange factor (GEF). Rho GEFs directly activate Rho by
inducing GDP^GTP exchange in response to extracellular
stimuli [10]. Activated GK13, but not GK12 or GKq, directly
stimulates the intrinsic activity of p115 Rho GEF, leading to
Rho activation [11].
In contrast to the GK12 family, there is con£icting evidence
concerning the role of GKq in Rho stimulation. The ubiqui-
tous GKq is a key GTPase that activates phospholipase CL,
resulting in Ca2þ in£ux and protein kinase C activation [12] in
response to many stimuli. The GKq family includes Kq/11,
K14 and K15, of which K14 and K15 show restricted tissue
expression [13]. Originally, activated GKq was reported to
be inactive in inducing actin stress ¢ber formation in ¢bro-
blasts [9] and SRF activation [14]. In contrast, others ob-
served that GKq signals could induce Rho-dependent re-
sponses such as neurite retraction [15], astrocytoma cell
rounding [16] and SRF activation [17].
In addition to these con£icting ¢ndings, there are contrast-
ing reports on potential mechanisms of GKq-induced Rho
responses. One unresolved issue has been whether GKq can
induce direct Rho activation, e.g. GTP-Rho formation in
vivo, since some reports found that GKq induces weak or
no GTP-Rho formation [16,18], while others report signi¢cant
GTP-Rho formation following GKq expression [19]. Further
uncertainty concerns the role of Rho GEFs in GKq-induced
Rho signals. GKq does not stimulate p115 Rho GEF as does
GK13 [11] ; therefore, it must induce Rho signals by a di¡erent
pathway(s), possibly via a di¡erent Rho GEF. However, the
precise involvement of Rho GEFs in GKq signals remains to
be de¢ned.
The aim of this study is to clarify the role of GKq in Rho
signaling. By using three independent assays, our results show
that expression of GKq family members is su⁄cient to induce
Rho activation and Rho-dependent cellular responses, includ-
ing, for the ¢rst time, actin stress ¢ber formation in ¢bro-
blasts.
2. Materials and methods
2.1. Cell lines and reagents
HEK293T cell line was from ATCC. Quiescent serum-starved Swiss
3T3 ¢broblasts were prepared as described [20]. Carbachol and iso-
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proterenol were from Sigma; Rho kinase inhibitor Y27632 was from
Wil¢de Co. (Osaka, Japan).
2.2. Plasmids
Wild-type and activated GKq Q209L, GK11 Q209L, GK14 Q205L,
GK15 Q212L, GK12 Q231L, GK13 Q226L, GKs Q213L, and M1
muscarinic and L2-adrenergic receptor cDNAs in pcDNA3 vector
were obtained from Guthrie cDNA Resource. pBN112-GKq Q209L
expression vector was obtained from ATCC. The SRE.L luciferase
reporter, pEFC3 transferase, pGEX2T Rhotekin RBD and p115
Rho GEF plasmids were gifts. pEXVRhoV14, pEXVRacL61 and
pSR-wt-Lbc:Flag are described in [8,21].
2.3. Antibodies
Anti-RhoA and anti-GK-subunit antibodies were from Santa Cruz.
2.4. Cell transfection
Cells at 70% con£uence (six well dishes for reporter assays, 100 mm
dishes for RBD assays) were transfected using Lipofectamine Plus
(Gibco BRL).
2.5. Immunoblotting
Cellular material was resolved by 10% SDS^PAGE. Immunoblot-
ting was carried out as described in [16].
2.6. Dual luciferase reporter assay
SRE.L luciferase reporter plasmid, which encodes a mutant SRE
that contains SRF binding sites, but eliminates the ternary complex
factor binding site [3], was used. Twenty-four hours following
HEK293T transfection, luciferase assays were performed using the
Dual-Luciferase Reporter Assay System (Promega). Results were nor-
malized by sequential measurement of the internal control Renilla and
experimental ¢re£y luciferase levels by luminometer. Each point was
performed in triplicate.
2.7. RBD assay
HEK293T were transfected with plasmids and serum-starved over-
night before harvesting. After 24 h, a portion of the cell lysate was
incubated with a⁄nity gel-bound GST-Rhotekin Rho binding domain
(RBD) fusion protein which speci¢cally binds GTP-Rho, and a⁄nity
puri¢cation was performed as described [22]. Total cell lysate or pull-
down material was resolved by 10% SDS^PAGE, followed by immu-
noblotting with anti-RhoA antibody.
2.8. Microinjection
Quiescent Swiss 3T3 ¢broblasts were injected with expression plas-
mids for GK12 Q205L, GKq Q209L or GK13 Q226L (16^50 Wg/ml).
Two to four hours after injection, cells were ¢xed and actin visualized
by TRITC^phalloidin staining as described [20]. Injected cells were
identi¢ed by coinjection of an injection marker. For some experi-
ments, C3 transferase expression vector was coinjected, or cells were
treated with 5 WM of Rho kinase inhibitor Y27632 from the time of
injection.
3. Results and discussion
3.1. Induction of SRE reporter activation by GKq members
Since activation of SRF by extracellular factors requires
Rho function [3], we tested the ability of GKq members to
induce SRE.L luciferase reporter activity. As shown in Fig.
1A, expression of activated mutant GKq family members Kq,
K11, K14, and K15 induced substantial SRE luciferase reporter
activity. In contrast, expression of activated GKs had no ef-
fect, whereas activated GK12/13 led to robust luciferase re-
porter induction. Furthermore, Fig. 1A shows that coexpres-
sion of C3 transferase, which inactivates Rho, blocked GKq
member-induced SRE reporter activation, demonstrating that
the response is Rho-dependent in each case. A positive control
was provided by expression of activated RhoV14 which in-
duced C3-sensitive luciferase reporter activity. In contrast,
SRE reporter induction by activated RacL61 was not blocked
by C3 transferase coexpression, indicating the target selectiv-
ity of C3 to Rho. The ¢nding that GKq members induce
substantial SRE.L reporter activity via Rho is in agreement
with earlier reports [16,17].
3.2. Induction of GTP-Rho formation by GKq members
To further investigate the observed response, the e¡ect of
expression of GKq members on Rho activity was determined
by measuring changes in GTP-Rho levels in HEK293T cells
by the GTP-Rho pull-down assay. As shown in Fig. 1B, ex-
pression of activated GKq, K11, K14 or K15 reproducibly
caused increased GTP-Rho levels in vivo of at least four-
fold. As expected, activated GK12 or GK13 expression also
led to increased GTP-Rho levels. In contrast, expression of
activated GKs, which does not stimulate Rho responses, had
no e¡ect. In contrast to some previous studies [16,18], our
¢nding of GKq-induced increases in GTP-Rho levels is con-
sistent with the observed SRE reporter activation via Rho,
and in agreement with the recent ¢nding of Chikumi et al.
[19].
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Fig. 1. GKq members stimulate SRE.L luciferase reporter activity,
and GTP-Rho formation. A: Activated GKq members were coex-
pressed in HEK293T with SRE.L luciferase reporter, and dual lucif-
erase assay carried out. RLU= relative luciferase units. * indicates
activated mutant GTPase forms described in Section 2.2; V= vector.
Results shown are meanSS.D. B: Following activated GKq member
expression in HEK293T, GTP-Rho pull-down was carried out.
RhoA immunoblot of the GTP-Rho pull-down (upper panel) and
total cellular Rho (lower panel) from a representative experiment
are shown. Graph shows mean fold increase in GTP-Rho densito-
metric values normalized to vector from at least two experiments.
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3.3. Induction of GTP-Rho formation by GKq-linked GPCR
We next tested whether activation of endogenous GKq sig-
nals results in Rho signaling and activation by expressing M1
muscarinic receptor cDNA, a speci¢c GKq-linked GPCR [23],
in HEK293T, and stimulating with the agonist carbachol. Fig.
2A shows that carbachol treatment led to substantial SRE
reporter activation which was blocked by C3 transferase coex-
pression. Next, the e¡ect of M1 muscarinic receptor stimula-
tion on GTP-Rho levels was measured. Fig. 2B shows that
compared to non-stimulated cells, carbachol stimulation of
cells expressing M1 muscarinic receptor led to increased
GTP-Rho levels. In contrast, stimulation of cells expressing
a GKs-linked GPCR, L2-adrenergic receptor by the agonist
isoproterenol, had no e¡ect on GTP-Rho levels. Taken to-
gether, the ¢ndings that exogenous expression of activated
GKq, or stimulation of endogenous GKq signals, leads to
Rho signals and GTP-Rho formation support the notion
that GKq signals are su⁄cient to activate Rho.
3.4. Induction of Rho-dependent actin ¢lament assembly by
GKq
We next investigated the e¡ect of GKq actin cytoskeletal
responses. As shown in Fig. 3A,B, expression of activated
pBN-GKq Q209L in quiescent Swiss 3T3 ¢broblasts by micro-
injection induced a very strong stress ¢ber response in 75^
100% of the injected cells within 2^4 h of injection, while there
was no response in control-injected cells (not shown). To en-
sure that stress ¢ber induction resulted from the GKq Q209L
sequence, the GKq Q209L cDNA was subcloned into
pcDNA3 and resequenced. Microinjection of pcDNA3-GKq
Q209L gave identical results to pBN-GKq Q209L expression.
To investigate the role of Rho in GKq-induced stress ¢ber
formation we coinjected the pEFC3 transferase plasmid with
GKq Q209L. Upon coexpression stress ¢ber formation was
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Fig. 2. GKq-linked GPCR stimulation induces SRE reporter activa-
tion and GTP-Rho formation. A: HEK293T cells were transfected
with SRE.L luciferase reporter and either vector, pcDNA:M1 mus-
carinic receptor (Mus-M1R) or pcDNA:L2-adrenergic receptor
(L2-ADR). Following stimulation with 100 WM carbachol (CARB)
or 10 WM isoproterenol (ISO) for 6 h, dual luciferase assay was car-
ried out. Results shown are meanSS.D. B: HEK293T cells were
transfected with 1 Wg of vector or GPCR plasmid. After overnight
serum starvation, cells were stimulated with 100 WM carbachol for
10 min, followed by GTP-Rho pull-down. RhoA immunoblot of the
GTP-Rho pull-down (upper panel) and total cellular Rho (lower
panel) from a representative experiment are shown. Graph shows
mean fold increase in GTP-Rho densitometric values normalized to
vector from at least two experiments.
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Fig. 3. Activated GKq expression induces actin stress ¢ber forma-
tion. A: Con£uent quiescent Swiss 3T3 cells were injected with indi-
cated expression vectors with or without Y27632, and the actin cy-
toskeleton visualized. Percentages of injected cells exhibiting strong
stress ¢ber (SF) formation are shown as meanSS.D. of at least
three experiments each examining 100 injected cells. Typical mor-
phologies of cells expressing GKq Q209L (B); GKq Q209L and C3
(C); and GKq Q209L+Y27632 (D). Arrows indicate injected cells.
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inhibited in approximately 45% of the cells (Fig. 3A,C), while
10% of cells retained stress ¢bers. Thus, we show here for the
¢rst time that expression of activated GKq is capable of in-
ducing robust actin stress ¢ber formation in ¢broblasts via
Rho. This is in contrast to previous reports that GKq is in-
active in stress ¢ber formation [9,24]. While the reason for the
discrepancy between these studies and ours is not clear, it
should be noted that Gohla et al. [24] used a di¡erent acti-
vated GKq mutant (GKq R183C) and that Buhl et al. [9] did
note some subtle di¡erences in the appearance of the actin
cytoskeleton upon GKq Q209L expression. In addition our
results are consistent with reports on GKq-induced neurite
retraction and astrocytoma cell rounding [15,16], which both
require actin cytoskeletal rearrangements. In addition, in qui-
escent ¢broblasts, C3 and GKq Q209L coexpression resulted
in rounding up of about 45% of the cells (Fig. 3A), although
C3 alone or in combination with GK13 Q226L did not (not
shown). The speci¢c coexpression of GKq Q209L and C3 in
serum-starved ¢broblasts may cause this e¡ect, but its molec-
ular basis remains to be de¢ned.
Next, the role of the Rho downstream e¡ector Rho kinase
in GKq-induced stress ¢ber formation was determined. Treat-
ment of cells with the Rho kinase inhibitor Y27632 inhibited
the internal stress ¢ber formation induced by GKq, resulting
in stress ¢ber inhibition in 75% of the cells (Fig. 3A,D). We
conclude that activated GKq is a potent inducer of actin stress
¢ber formation in quiescent ¢broblasts through a Rho- and
Rho kinase-dependent pathway. While Y27632 caused an al-
most total disappearance of internal stress ¢bers in GKq-ex-
pressing cells, the cells still appeared to be contracted along
the cortical rim with several actin-rich spikes or retraction
¢bers occurring. In light of reports that myosin light chain
kinase (MLCK) activity is associated with actin ¢ber forma-
tion at the periphery/cortical border of the cell, while Rho
kinase is primarily involved in internal stress ¢ber formation
[25,26], it can be speculated that GKq may induce both
MLCK and Rho kinase activation.
3.5. Involvement of Rho GEFs in GKq-induced Rho signals
We next analyzed potential mechanisms of GKq-induced
Rho signals by assessing the ability of two Rho-speci¢c
GEFs, Lbc and p115 Rho GEF, to functionally cooperate
in GKq family-induced signals. Fig. 4A shows that coexpres-
sion of full-length wild-type Lbc with GKq, GK14, or GK15
results in increased SRE luciferase reporter activity of up to
three-fold, without changes in GKq subunit expression. In
Fig. 4. Functional cooperativity of GKq members with Lbc Rho GEF. A,B: Activated GKq members were coexpressed with either wild-type
Lbc (A) or p115 Rho GEF (B) in HEK293T with SRE.L luciferase reporter, and dual luciferase assay carried out. RLU= relative luciferase
units. Results shown are meanSS.D. Lower panel is an immunoblot of total cellular GKq and GK15 expression levels in the presence of Lbc.
C,D: Activated GKq members were coexpressed with either wild-type Lbc (C) or p115 Rho GEF (D) in HEK293T, and GTP-Rho pull-down
carried out. RhoA immunoblot of the GTP-Rho pull-down (upper panel) and total cellular Rho (lower panel) from a representative experiment
are shown. Graphs below the immunoblot panels show mean fold increase in GTP-Rho densitometric values normalized to vector from at least
two experiments.
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contrast, coexpression of full-length p115 Rho GEF with GKq
members results in more modest cooperativity. Furthermore,
Fig. 4B shows that coexpression of Lbc with GKq or GK14
caused increased GTP-Rho formation in vivo as measured by
RBD pull-down experiments. This result is consistent with the
signaling cooperativity observed in SRE reporter activation.
In comparison, p115 Rho GEF coexpression with GKq mem-
bers led to little or no cooperativity in inducing GTP-Rho
formation.
These results suggest that GKq or GK14 signals show a
greater enhancement with Lbc as compared to p115 Rho
GEF. GK15 showed less cooperativity with Lbc compared
to GKq or GK14; while the reason for this is unclear, it
may re£ect di¡erences between GKq family members and their
potential cognate Rho GEFs, analogous to the ¢nding that
p115 Rho GEF is only stimulated by GK13, but not by its
close relative GK12 [11]. The observed functional cooperativ-
ity is consistent with the previous ¢nding that while Lbc
physically associates with GKq [16], p115 GEF neither directly
associates with, nor transduces GKq signals [11]. GKq also
functionally cooperates and associates with LARG GEF
[27], presenting the possibility that GKq may induce Rho sig-
nals via a Rho GEF such as Lbc and/or LARG GEF in vivo,
and this remains to be directly demonstrated. Whether or not
the precise mechanistic link between GKq and Rho GEFs will
have the same basis as the GK13-activated p115 Rho GEF
paradigm remains to be determined. In summary, our ¢ndings
de¢nitively extend the signaling pathways of GKq-linked
GPCRs to include Rho activation, and Rho-dependent tran-
scriptional and actin cytoskeletal responses.
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